Scotton W, Botfield H, Westgate C, Mitchell J, Yiangou A, Uldall M, et al. Topiramate is more effective than acetazolamide at lowering intracranial pressure. Cephalalgia. 2019;39:209-218 pubmed publisher

Mehand M, Srinivasan B, De Crescenzo G. Optimizing Multiple Analyte Injections in Surface Plasmon Resonance Biosensors with Analytes having Different Refractive Index Increments. Sci Rep. 2015;5:15855 pubmed publisher

Heidarimoghadam R, Farmany A. Rapid determination of furosemide in drug and blood plasma of wrestlers by a carboxyl-MWCNT sensor. Mater Sci Eng C Mater Biol Appl. 2016;58:1242-5 pubmed publisher

Svanbäck S, Ehlers H, Antikainen O, Yliruusi J. High-Speed Intrinsic Dissolution Rate in One Minute Using the Single-Particle Intrinsic Dissolution Rate Method. Anal Chem. 2015;87:11058-64 pubmed publisher

Kinouchi H, Matsuyama K, Kitagawa H, Kamimori H. Surface plasmon resonance assay of inhibition by pharmaceuticals for thyroxine hormone binging to transport proteins. Anal Biochem. 2016;492:43-8 pubmed publisher

Cui H, Zhang Q, Wang J, Chen J, Zhang Y, Tong X. Poor permeability and absorption affect the activity of four alkaloids from Coptis. Mol Med Rep. 2015;12:7160-8 pubmed publisher

Bobermin L, Hansel G, Scherer E, Wyse A, Souza D, Quincozes Santos A, et al. Ammonia impairs glutamatergic communication in astroglial cells: protective role of resveratrol. Toxicol In Vitro. 2015;29:2022-9 pubmed publisher

Katsura S, Yamada N, Nakashima A, Shiraishi S, Furuishi T, Ueda H. Identification of Furosemide Photodegradation Products in Water-Acetonitrile Mixture. Chem Pharm Bull (Tokyo). 2015;63:617-27 pubmed publisher

Smith C, Walker L, Chua B, McKinley M, Gundlach A, Denton D, et al. Involvement of central relaxin-3 signalling in sodium (salt) appetite. Exp Physiol. 2015;100:1064-72 pubmed publisher

Lidbury J, Ivanek R, Suchodolski J, Steiner J. Putative precipitating factors for hepatic encephalopathy in dogs: 118 cases (1991-2014). J Am Vet Med Assoc. 2015;247:176-83 pubmed publisher

Myung J, Hong S, DeWoskin D, De Schutter E, Forger D, Takumi T. GABA-mediated repulsive coupling between circadian clock neurons in the SCN encodes seasonal time. Proc Natl Acad Sci U S A. 2015;112:E3920-9 pubmed publisher

Gautschi N, van Hoogevest P, Kuentz M. Amorphous drug dispersions with mono- and diacyl lecithin: On molecular categorization of their feasibility and UV dissolution imaging. Int J Pharm. 2015;491:218-30 pubmed publisher

Adam O, Zimmer C, Hanke N, Hartmann R, Klemmer B, Böhm M, et al. Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice. J Mol Cell Cardiol. 2015;85:140-50 pubmed publisher

Pál I, Kardos J, Dobolyi Ã, Héja L. Appearance of fast astrocytic component in voltage-sensitive dye imaging of neural activity. Mol Brain. 2015;8:35 pubmed publisher

Taylor A, Castonguay A, Taylor A, Murphy N, Ghogha A, Cook C, et al. Microglia disrupt mesolimbic reward circuitry in chronic pain. J Neurosci. 2015;35:8442-50 pubmed publisher

Nielsen L, Rades T, Müllertz A. Stabilisation of amorphous furosemide increases the oral drug bioavailability in rats. Int J Pharm. 2015;490:334-40 pubmed publisher

Toma C, Olah N, Vlase L, Mogosan C, Mocan A. Comparative Studies on Polyphenolic Composition, Antioxidant and Diuretic Effects of Nigella sativa L. (Black Cumin) and Nigella damascena L. (Lady-in-a-Mist) Seeds. Molecules. 2015;20:9560-74 pubmed publisher

Basse W, Gutowska M, Findeisen U, Stumpp M, Dupont S, Jackson D, et al. A sea urchin Na(+)K(+)2Cl(-) cotransporter is involved in the maintenance of calcification-relevant cytoplasmic cords in Strongylocentrotus droebachiensis larvae. Comp Biochem Physiol A Mol Integr Physiol. 2015;187:184-92 pubmed publisher

Ebner T, Ishiguro N, Taub M. The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail. J Pharm Sci. 2015;104:3220-8 pubmed publisher

Mòdol L, Santos D, Cobianchi S, González Pérez F, López Alvarez V, Navarro X. NKCC1 Activation Is Required for Myelinated Sensory Neurons Regeneration through JNK-Dependent Pathway. J Neurosci. 2015;35:7414-27 pubmed publisher

Xu D, Michie S, Zheng M, Takeda S, Wu M, Peltz G. Humanized thymidine kinase-NOG mice can be used to identify drugs that cause animal-specific hepatotoxicity: a case study with furosemide. J Pharmacol Exp Ther. 2015;354:73-8 pubmed publisher

Tomida T, Okamura H, Satsukawa M, Yokoi T, Konno Y. Multiparametric assay using HepaRG cells for predicting drug-induced liver injury. Toxicol Lett. 2015;236:16-24 pubmed publisher

Youssef M, Mahmoud A, Abdelghany R. A new combination of sitagliptin and furosemide protects against remote myocardial injury induced by renal ischemia/reperfusion in rats. Biochem Pharmacol. 2015;96:20-9 pubmed publisher

Xing D, Wu Y, Li G, Song S, Liu Y, Liu H, et al. Role of cerebrospinal fluid-contacting nucleus in sodium sensing and sodium appetite. Physiol Behav. 2015;147:291-9 pubmed publisher

Lozoya Agulló I, Gonzalez Alvarez I, Gonzalez Alvarez M, Merino Sanjuán M, Bermejo M. In Situ Perfusion Model in Rat Colon for Drug Absorption Studies: Comparison with Small Intestine and Caco-2 Cell Model. J Pharm Sci. 2015;104:3136-45 pubmed publisher

Asif M, Jabeen Q, Abdul Majid A, Atif M. Diuretic activity of aqueous extract of Nigella sativa in albino rats. Acta Pol Pharm. 2015;72:129-35 pubmed

Lai C, Wu C, Kuo R, Yang Y, Chen M, Chan K, et al. Clinical outcomes in low risk coronary artery disease patients treated with different limus-based drug-eluting stents--a nationwide retrospective cohort study using insurance claims database. PLoS ONE. 2015;10:e0122860 pubmed publisher

Oda S, Fujiwara R, Kutsuno Y, Fukami T, Itoh T, Yokoi T, et al. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast. Drug Metab Dispos. 2015;43:812-8 pubmed publisher

Rabbie S, Flanagan T, Martin P, Basit A. Inter-subject variability in intestinal drug solubility. Int J Pharm. 2015;485:229-34 pubmed publisher

Axelsson J, Rippe A, Rippe B. mTOR inhibition with temsirolimus causes acute increases in glomerular permeability, but inhibits the dynamic permeability actions of puromycin aminonucleoside. Am J Physiol Renal Physiol. 2015;308:F1056-64 pubmed publisher

Chang W, Lu H, Shyu B. Treatment with direct-current stimulation against cingulate seizure-like activity induced by 4-aminopyridine and bicuculline in an in vitro mouse model. Exp Neurol. 2015;265:180-92 pubmed publisher

Wu B, Rambow J, Bock S, Holm Bertelsen J, Wiechert M, Soares A, et al. Identity of a Plasmodium lactate/H(+) symporter structurally unrelated to human transporters. Nat Commun. 2015;6:6284 pubmed publisher

McNaughton A, Frasca S, Mishra N, Tuttle A. Valvular dysplasia and congestive heart failure in a juvenile African penguin (Spheniscus demersus). J Zoo Wildl Med. 2014;45:987-90 pubmed

Magiera S, Baranowska I. A rapid method for determination of 22 selected drugs in human urine by UHPLC/MS/MS for clinical application. J AOAC Int. 2014;97:1526-37 pubmed

Thacker E, Jensen P, Psaty B, McKnight B, Longstreth W, Dublin S, et al. Use of statins and antihypertensive medications in relation to risk of long-standing persistent atrial fibrillation. Ann Pharmacother. 2015;49:378-86 pubmed publisher

DeVore A, Hasselblad V, Mentz R, O Connor C, Armstrong P, McMurray J, et al. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF. Eur J Heart Fail. 2015;17:340-6 pubmed publisher

Pigeat R, Chausson P, Dreyfus F, Leresche N, Lambert R. Sleep slow wave-related homo and heterosynaptic LTD of intrathalamic GABAAergic synapses: involvement of T-type Ca2+ channels and metabotropic glutamate receptors. J Neurosci. 2015;35:64-73 pubmed publisher

Pinder N, Zimmermann J, Hofer S, Brenner T, Weigand M, Gubbe U, et al. Revival of physostigmine - a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patients. Clin Chem Lab Med. 2015;53:1259-64 pubmed publisher

Roumie C, Zillich A, Bravata D, Jaynes H, Myers L, Yoder J, et al. Hypertension treatment intensification among stroke survivors with uncontrolled blood pressure. Stroke. 2015;46:465-70 pubmed publisher

Miller T, McEneff G, Brown R, Owen S, Bury N, Barron L. Pharmaceuticals in the freshwater invertebrate, Gammarus pulex, determined using pulverised liquid extraction, solid phase extraction and liquid chromatography-tandem mass spectrometry. Sci Total Environ. 2015;511:153-60 pubmed publisher

Markovič T, Gobec M, Gurwitz D, Mlinarič Raščan I. Characterization of human lymphoblastoid cell lines as a novel in vitro test system to predict the immunotoxicity of xenobiotics. Toxicol Lett. 2015;233:8-15 pubmed publisher

Cheng C, Yoon J, Baum M, Huang C. STE20/SPS1-related proline/alanine-rich kinase (SPAK) is critical for sodium reabsorption in isolated, perfused thick ascending limb. Am J Physiol Renal Physiol. 2015;308:F437-43 pubmed publisher

Nováková L, Rentsch M, Grand Guillaume Perrenoud A, Nicoli R, Saugy M, Veuthey J, et al. Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. II: Analysis of biological samples. Anal Chim Acta. 2015;853:647-59 pubmed publisher

Nováková L, Grand Guillaume Perrenoud A, Nicoli R, Saugy M, Veuthey J, Guillarme D. Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. I: Investigation of mobile phase and MS conditions. Anal Chim Acta. 2015;853:637-46 pubmed publisher

Reyes Garcés N, Bojko B, Pawliszyn J. High throughput quantification of prohibited substances in plasma using thin film solid phase microextraction. J Chromatogr A. 2014;1374:40-49 pubmed publisher

Lescano C, Iwamoto R, Sanjinez Argandoña E, Kassuya C. Diuretic and Anti-Inflammatory Activities of the Microencapsulated Acrocomia aculeata (Arecaceae) Oil on Wistar Rats. J Med Food. 2015;18:656-62 pubmed publisher

Komasaka T, Fujimura H, Tagawa T, Sugiyama A, Kitano Y. Practical method for preparing nanosuspension formulations for toxicology studies in the discovery stage: formulation optimization and in vitro/in vivo evaluation of nanosized poorly water-soluble compounds. Chem Pharm Bull (Tokyo). 2014;62:1073-82 pubmed

Hurley S, Zhang Z, Beltz T, Xue B, Johnson A. Sensitization of sodium appetite: evidence for sustained molecular changes in the lamina terminalis. Am J Physiol Regul Integr Comp Physiol. 2014;307:R1405-12 pubmed publisher

Moreira M, da Silva E, Silveira L, de Paiva Y, de Castro C, Freiria Oliveira A, et al. High sodium intake during postnatal phases induces an increase in arterial blood pressure in adult rats. Br J Nutr. 2014;112:1923-32 pubmed publisher

Lantis A, Ames M, Atkins C, DeFrancesco T, Keene B, Werre S. Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs. J Vet Pharmacol Ther. 2015;38:65-73 pubmed publisher

Alexandrou A, Armeni E, Kaparos G, Rizos D, Tsoka E, Deligeoroglou E, et al. Bsm1 vitamin D receptor polymorphism and calcium homeostasis following bariatric surgery. J Invest Surg. 2015;28:8-17 pubmed publisher

Laurencé C, Rivard M, Martens T, Morin C, Buisson D, Bourcier S, et al. Anticipating the fate and impact of organic environmental contaminants: a new approach applied to the pharmaceutical furosemide. Chemosphere. 2014;113:193-9 pubmed publisher

Atkinson P, Wise A, Flynn B, Nayagam B, Richardson R. Hair cell regeneration after ATOH1 gene therapy in the cochlea of profoundly deaf adult guinea pigs. PLoS ONE. 2014;9:e102077 pubmed publisher

Murtaza G, Khan S, Najam ul Haq M, Hussain I. Comparative evaluation of various solubility enhancement strategies for furosemide. Pak J Pharm Sci. 2014;27:963-73 pubmed

Kuroki M, Fink G, Osborn J. Comparison of arterial pressure and plasma ANG II responses to three methods of subcutaneous ANG II administration. Am J Physiol Heart Circ Physiol. 2014;307:H670-9 pubmed publisher

Silva P, Monnerat Cahli G, Pereira Acácio A, Luzardo R, Sampaio L, Luna Leite M, et al. Mechanisms involving Ang II and MAPK/ERK1/2 signaling pathways underlie cardiac and renal alterations during chronic undernutrition. PLoS ONE. 2014;9:e100410 pubmed publisher

Arumugam S, Sreedhar R, Miyashita S, Karuppagounder V, Thandavarayan R, Giridharan V, et al. Comparative evaluation of torasemide and furosemide on rats with streptozotocin-induced diabetic nephropathy. Exp Mol Pathol. 2014;97:137-43 pubmed publisher

Raidal S, Hughes K, Charman A, Nielsen S, Phillips J, Noble G. Effects of meloxicam and phenylbutazone on renal responses to furosemide, dobutamine, and exercise in horses. Am J Vet Res. 2014;75:668-79 pubmed publisher

Baeza Baeza J, García Álvarez Coque M. Some insights on the description of gradient elution in reversed-phase liquid chromatography. J Sep Sci. 2014;37:2269-77 pubmed publisher

Shiozaki A, Nako Y, Ichikawa D, Konishi H, Komatsu S, Kubota T, et al. Role of the Na ⁺/K ⁺/2Cl⁻ cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinoma. World J Gastroenterol. 2014;20:6844-59 pubmed publisher

Sarraguça M, Ribeiro P, Santos A, Silva M, Lopes J. A PAT approach for the on-line monitoring of pharmaceutical co-crystals formation with near infrared spectroscopy. Int J Pharm. 2014;471:478-84 pubmed publisher

Carrisoza Gaytán R, Liu Y, Flores D, Else C, Lee H, Rhodes G, et al. Effects of biomechanical forces on signaling in the cortical collecting duct (CCD). Am J Physiol Renal Physiol. 2014;307:F195-204 pubmed publisher

Li L, Thacker J, Lu J, Franklin T, Zhou Y, Papadopoulou M, et al. Efficacy of preventive interventions for iodinated contrast-induced acute kidney injury evaluated by intrarenal oxygenation as an early marker. Invest Radiol. 2014;49:647-52 pubmed publisher

Uehara K, Tagami T, Miyazaki I, Murata N, Takahashi Y, Ohkubo H, et al. Effect of X-ray exposure on the pharmaceutical quality of drug tablets using X-ray inspection equipment. Drug Dev Ind Pharm. 2015;41:953-8 pubmed publisher

Shah D, Mavani D, Patel H, Baldania S, Bhatt K, Chhalotiya U. Development and validation of liquid chromatography-tandem mass spectrometric method for the quantification of ciprofibrate from human plasma. J Chromatogr Sci. 2015;53:219-25 pubmed publisher

Slack J, Boston R, Soma L, Reef V. Occurrence of cardiac arrhythmias in Standardbred racehorses. Equine Vet J. 2015;47:398-404 pubmed publisher

Qu Q, Liu J, Zhou H, Klaassen C. Nrf2 protects against furosemide-induced hepatotoxicity. Toxicology. 2014;324:35-42 pubmed publisher

Davies M, Fraser S, Galic S, Choy S, Katerelos M, Gleich K, et al. Novel mechanisms of Na+ retention in obesity: phosphorylation of NKCC2 and regulation of SPAK/OSR1 by AMPK. Am J Physiol Renal Physiol. 2014;307:F96-F106 pubmed publisher

Taylor A. Radionuclides in nephrourology, Part 2: pitfalls and diagnostic applications. J Nucl Med. 2014;55:786-98 pubmed publisher

Jinno N, Tagashira M, Tsurui K, Yamada S. Contribution of cytochrome P450 and UDT-glucuronosyltransferase to the metabolism of drugs containing carboxylic acid groups: risk assessment of acylglucuronides using human hepatocytes. Xenobiotica. 2014;44:677-86 pubmed publisher

Pistolozzi M, Fortugno C, Franchini C, Corbo F, Muraglia M, Roy M, et al. Species-dependent binding of tocainide analogues to albumin: affinity chromatography and circular dichroism study. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;968:69-78 pubmed publisher

Austin J, Hockey D, Williams W, Hutchison S. Assessing parenteral diuretic treatment of decompensated heart failure in the community. Br J Community Nurs. 2013;18:528, 530-4 pubmed

Schmitz H, Johnson S, Santi P. Kanamycin-furosemide ototoxicity in the mouse cochlea: a 3-dimensional analysis. Otolaryngol Head Neck Surg. 2014;150:666-72 pubmed publisher

Okamoto Y, Nohmi T, Seki K, Higa Y. [Planning of cardiothoracic surgery for chronic kidney disease patients]. Masui. 2013;62:1320-5 pubmed

Wu F, Mi W, Cannon S. Beneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis. Brain. 2013;136:3766-74 pubmed publisher

Thajudeen B, Rubin M. Hemodynamic acute kidney injury in immunoglobulin A nephropathy: nephrosarca theory revisited. Am J Med. 2013;126:e13-4 pubmed publisher

Peng X, Bai Y, Fang F, Wang X, Mao H, Teng G, et al. Renal lipids and oxygenation in diabetic mice: noninvasive quantification with MR imaging. Radiology. 2013;269:748-57 pubmed publisher

Nau J. [What the Furosemide Teva situation did not tell us]. Rev Med Suisse. 2013;9:1334-5 pubmed

Zhu Y, Gu X, Zhu H, Yang X, Wang D, Yu P. [Influence of non-sodium restricted diet with diuretics on plasma rennin, renal blood flow and in patients with cirrhotic ascites]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013;27:50-3 pubmed

Mesbahzadeh B, Ajalloueyan M, Kaka G, Askari A, Hasanalifard M. A model portraying experimental loss of hair cell: the use of distortion product otoacoustic emission in the assessment of rat's ear. Pak J Pharm Sci. 2013;26:767-71 pubmed

Pitsiou G, Paspala A, Bagalas V, Boutou A, Stanopoulos I. Inhaled iloprost plus levosimendan to decompensate right heart failure due to chronic thromboembolic pulmonary hypertension. Anaesth Intensive Care. 2013;41:554-6 pubmed

Ricci F, Ramírez T, Marmorato R, Vega J, Pagan P, Lopez J, et al. Predisposing factors for acute kidney injury in Hispanic patients treated with diuretics for decompensated heart failure. P R Health Sci J. 2013;32:63-7 pubmed

Hernandez R, Madero M. [Hyponatremia]. Rev Invest Clin. 2013;65:74-87 pubmed

Kassab M, Khriesat W, Bawadi H, Anabrees J. Furosemide for transient tachypnoea of the newborn. Cochrane Database Syst Rev. 2013;:CD003064 pubmed publisher

Solymosi E, Kaestle Gembardt S, Vadász I, Wang L, Neye N, Chupin C, et al. Chloride transport-driven alveolar fluid secretion is a major contributor to cardiogenic lung edema. Proc Natl Acad Sci U S A. 2013;110:E2308-16 pubmed publisher

Windsor R, Petchey W. Metabolic alkalosis in a patient with dyspnoea. BMJ. 2013;346:f2710 pubmed publisher

Carels K, Herpels V, Cardoen L, Lecluyse C, Traen S, Verschakelen J. Postextubation pulmonary edema: an unusual cause of transient pulmonary edema. JBR-BTR. 2013;96:17-8 pubmed

McKinley M. Adaptive appetites for salted and unsalted food in rats: differential effects of sodium depletion, DOCA, and dehydration. Am J Physiol Regul Integr Comp Physiol. 2013;304:R1149-60 pubmed publisher

Gromadziński L, Januszko Giergielewicz B, Kubiak M, Pruszczyk P. Patient with purulent pericarditis: a case doomed to fail?. Kardiol Pol. 2013;71:176-8 pubmed publisher

Mauer A, Baron S, Yeh R, Scott N. Caesarian dissection: a case of chest pain and dyspnea during delivery. Circulation. 2013;127:1530-5 pubmed publisher

Legrand M, Payen D. Case scenario: Hemodynamic management of postoperative acute kidney injury. Anesthesiology. 2013;118:1446-54 pubmed publisher

Pandya G, Mukhopadhyay A, Ping C, Lim T. Unilateral lobar pulmonary edema. J Assoc Physicians India. 2012;60:60-2 pubmed

Garnero C, Chattah A, Longhi M. Supramolecular complexes of maltodextrin and furosemide polymorphs: a new approach for delivery systems. Carbohydr Polym. 2013;94:292-300 pubmed publisher

Sato N, Kajimoto K, Keida T, Mizuno M, Minami Y, Yumino D, et al. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). Circ J. 2013;77:944-51 pubmed

Bikdeli B, Strait K, Dharmarajan K, Partovian C, Coca S, Kim N, et al. Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?. J Am Coll Cardiol. 2013;61:1549-50 pubmed publisher

Slaughter J, Stenger M, Reagan P. Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia. Pediatrics. 2013;131:716-23 pubmed publisher

Casals G, Fábregues F, Pavesi M, Arroyo V, Balasch J. Conservative medical treatment of ovarian hyperstimulation syndrome: a single center series and cost analysis study. Acta Obstet Gynecol Scand. 2013;92:686-91 pubmed publisher

Waaijer L, Klis S, Ramekers D, Van Deurzen M, Hendriksen F, Grolman W. The peripheral processes of spiral ganglion cells after intracochlear application of brain-derived neurotrophic factor in deafened guinea pigs. Otol Neurotol. 2013;34:570-8 pubmed publisher

Fischer C, Ferdynus C, Gouyon J, Semama D. Doxapram and hypokalaemia in very preterm infants. Arch Dis Child Fetal Neonatal Ed. 2013;98:F416-8 pubmed publisher

Wang L, Papangelou A, Lin C, Mirski M, Gottschalk A, Toung T. Comparison of equivolume, equiosmolar solutions of mannitol and hypertonic saline with or without furosemide on brain water content in normal rats. Anesthesiology. 2013;118:903-13 pubmed publisher

Zaidi N, Ahmad E, Rehan M, Rabbani G, Ajmal M, Zaidi Y, et al. Biophysical insight into furosemide binding to human serum albumin: a study to unveil its impaired albumin binding in uremia. J Phys Chem B. 2013;117:2595-604 pubmed publisher

Koslow M, Raskin S, Sidi Y, Ben Dov I, Segel M. An 82-year-old woman with progressive dyspnea and bilateral infiltrates. Chest. 2013;143:571-574 pubmed publisher

Kandeel A, Elhossainy S, Elsayed N. Influence of early (F+0) intravenous furosemide injection on the split renal function using 99mTc-DTPA renography. Nucl Med Commun. 2013;34:354-8 pubmed publisher

. Furosemide in acute decompensated heart failure. Prescrire Int. 2012;21:303 pubmed

van Loon M, Ramekers D, Agterberg M, de Groot J, Grolman W, Klis S, et al. Spiral ganglion cell morphology in guinea pigs after deafening and neurotrophic treatment. Hear Res. 2013;298:17-26 pubmed publisher

Chao C, Chao J. Case report: furosemide and pancreatitis: Importance of dose and latency period before reaction. Can Fam Physician. 2013;59:43-5 pubmed

Todd M. Hyperosmolar therapy and the brain: a hundred years of hard-earned lessons. Anesthesiology. 2013;118:777-9 pubmed publisher

Raghunath A. Gingival pain: an unusual side effect of ziprasidone. BMJ Case Rep. 2013;2013: pubmed publisher

Gandhi A, Husain M, Salhiyyah K, Raja S. Does perioperative furosemide usage reduce the need for renal replacement therapy in cardiac surgery patients?. Interact Cardiovasc Thorac Surg. 2012;15:750-5 pubmed

Pacifici G. Clinical pharmacology of the loop diuretics furosemide and bumetanide in neonates and infants. Paediatr Drugs. 2012;14:233-46 pubmed publisher

Hochman D. The extracellular space and epileptic activity in the adult brain: explaining the antiepileptic effects of furosemide and bumetanide. Epilepsia. 2012;53 Suppl 1:18-25 pubmed publisher

Segar J. Neonatal diuretic therapy: furosemide, thiazides, and spironolactone. Clin Perinatol. 2012;39:209-20 pubmed publisher

Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS Comput Biol. 2011;7:e1002310 pubmed publisher

Amer M, Adomaityte J, Qayyum R. Continuous infusion versus intermittent bolus furosemide in ADHF: an updated meta-analysis of randomized control trials. J Hosp Med. 2012;7:270-5 pubmed publisher

Tuttolomondo A, Pinto A, Parrinello G, Licata G. Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites. Semin Nephrol. 2011;31:513-22 pubmed publisher

da Silva P, de Aguiar V, Fonseca M. Additive diuretic response of concurrent aminophylline and furosemide in children: a case series and a brief literature review. J Anesth. 2012;26:118-23 pubmed publisher

Doyon N, Prescott S, Castonguay A, Godin A, Kröger H, De Koninck Y. Efficacy of synaptic inhibition depends on multiple, dynamically interacting mechanisms implicated in chloride homeostasis. PLoS Comput Biol. 2011;7:e1002149 pubmed publisher

. Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit. Prescrire Int. 2011;20:156-60 pubmed

Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W. FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today. 2011;16:697-703 pubmed publisher

Wenlock M, Barton P, Luker T. Lipophilicity of acidic compounds: impact of ion pair partitioning on drug design. Bioorg Med Chem Lett. 2011;21:3550-6 pubmed publisher

Gozalbes R, Jacewicz M, Annand R, Tsaioun K, Pineda Lucena A. QSAR-based permeability model for drug-like compounds. Bioorg Med Chem. 2011;19:2615-24 pubmed publisher

Zacharias H, Raw J, Nunn A, Parsons S, Johnson M. Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure?. Palliat Med. 2011;25:658-63 pubmed publisher

Talevi A, Goodarzi M, Ortiz E, Duchowicz P, Bellera C, Pesce G, et al. Prediction of drug intestinal absorption by new linear and non-linear QSPR. Eur J Med Chem. 2011;46:218-28 pubmed publisher

Buttar D, Colclough N, Gerhardt S, Macfaul P, Phillips S, Plowright A, et al. A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions. Bioorg Med Chem. 2010;18:7486-96 pubmed publisher

Ekins S, Williams A, Xu J. A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug Metab Dispos. 2010;38:2302-8 pubmed publisher

Gozalbes R, Pineda Lucena A. QSAR-based solubility model for drug-like compounds. Bioorg Med Chem. 2010;18:7078-84 pubmed publisher

Inglis S, Clark R, McAlister F, Ball J, Lewinter C, Cullington D, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev. 2010;:CD007228 pubmed publisher

Fong J, Le Nihouannen D, Komarova S. Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase. J Biol Chem. 2010;285:31427-34 pubmed publisher

Greene N, Fisk L, Naven R, Note R, Patel M, Pelletier D. Developing structure-activity relationships for the prediction of hepatotoxicity. Chem Res Toxicol. 2010;23:1215-22 pubmed publisher

Avdeef A, Tam K. How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?. J Med Chem. 2010;53:3566-84 pubmed publisher

Hernández L, Salinas R, Cabrera M, Acosta G, Henríquez M, Quintana P, et al. Hypercalcemia worsened by the use of furosemide in a patient suffering from allopurinol-induced granulomatous hepatitis. Rev Esp Enferm Dig. 2010;102:147-8 pubmed

Pegurier C, Bosman N, Collart P, Delporte M, Leclercq K, Lengelé S, et al. Benzyl prolinate derivatives as novel selective KCC2 blockers. Bioorg Med Chem Lett. 2010;20:2542-5 pubmed publisher

Giacomini K, Huang S, Tweedie D, Benet L, Brouwer K, Chu X, et al. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9:215-36 pubmed publisher

Prado Prado F, Garcia Mera X, González Díaz H. Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorg Med Chem. 2010;18:2225-2231 pubmed publisher

Ho K, Power B. Benefits and risks of furosemide in acute kidney injury. Anaesthesia. 2010;65:283-93 pubmed publisher

Varma M, Obach R, Rotter C, Miller H, Chang G, Steyn S, et al. Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. J Med Chem. 2010;53:1098-108 pubmed publisher

Uehara T, Ono A, Maruyama T, Kato I, Yamada H, Ohno Y, et al. The Japanese toxicogenomics project: application of toxicogenomics. Mol Nutr Food Res. 2010;54:218-27 pubmed publisher

Guerra A, Campillo N, Paez J. Neural computational prediction of oral drug absorption based on CODES 2D descriptors. Eur J Med Chem. 2010;45:930-40 pubmed publisher

Kruhlak N, Choi S, Contrera J, Weaver J, Willard J, Hastings K, et al. Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicol Mech Methods. 2008;18:217-27 pubmed publisher

Fourches D, Barnes J, Day N, Bradley P, Reed J, Tropsha A. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol. 2010;23:171-83 pubmed publisher

Lee P, Conradi R, Shanmugasundaram V. Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay. Bioorg Med Chem Lett. 2010;20:69-73 pubmed publisher

Wargo K, Banta W. A comprehensive review of the loop diuretics: should furosemide be first line?. Ann Pharmacother. 2009;43:1836-47 pubmed publisher

Yuan J, Johnson R, Huang R, Wichterman J, Jiang H, Hayton K, et al. Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol. 2009;5:765-71 pubmed publisher

Du Cuny L, Song Z, Moses S, Powis G, Mash E, Meuillet E, et al. Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. Bioorg Med Chem. 2009;17:6983-92 pubmed publisher

Sui X, Sun J, Li H, Wang Y, Liu J, Liu X, et al. Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data. Eur J Med Chem. 2009;44:4455-60 pubmed publisher

Crowe A, Huang W, Ballatore C, Johnson R, Hogan A, Huang R, et al. Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening. Biochemistry. 2009;48:7732-45 pubmed publisher

Varma M, Feng B, Obach R, Troutman M, Chupka J, Miller H, et al. Physicochemical determinants of human renal clearance. J Med Chem. 2009;52:4844-52 pubmed publisher

Dreassi E, Zizzari A, Falchi F, Schenone S, Santucci A, Maga G, et al. Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data. Eur J Med Chem. 2009;44:3712-7 pubmed publisher

Gilligan P, Clarke T, He L, Lelas S, Li Y, Heman K, et al. Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists. J Med Chem. 2009;52:3084-92 pubmed publisher

Bhattacharya A, Mishra L, Sharma M, Awasthi S, Bhasin V. Antimalarial pharmacodynamics of chalcone derivatives in combination with artemisinin against Plasmodium falciparum in vitro. Eur J Med Chem. 2009;44:3388-93 pubmed publisher

Temperini C, Cecchi A, Scozzafava A, Supuran C. Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference. Bioorg Med Chem. 2009;17:1214-21 pubmed publisher

Nishino T. Pathophysiology of dyspnea evaluated by breath-holding test: studies of furosemide treatment. Respir Physiol Neurobiol. 2009;167:20-5 pubmed publisher

Pérez Garrido A, Morales Helguera A, Abellán Guillén A, Cordeiro M, Garrido Escudero A. Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins. Bioorg Med Chem. 2009;17:896-904 pubmed publisher

Santana L, González Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, et al. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem. 2008;51:6740-51 pubmed publisher

Ahlin G, Karlsson J, Pedersen J, Gustavsson L, Larsson R, Matsson P, et al. Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. J Med Chem. 2008;51:5932-42 pubmed publisher

Li H, Sun J, Sui X, Liu J, Yan Z, Liu X, et al. First-principle, structure-based prediction of hepatic metabolic clearance values in human. Eur J Med Chem. 2009;44:1600-6 pubmed publisher

Legrand S, Leskuski D, Zama I. Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Ann Intern Med. 2008;149:259-63 pubmed

Espinosa Bosch M, Ruiz Sanchez A, Sanchez Rojas F, Bosch Ojeda C. Recent developments in analytical determination of furosemide. J Pharm Biomed Anal. 2008;48:519-32 pubmed publisher

Yang H, Shen Y, Chen J, Jiang Q, Leng Y, Shen J. Structure-based virtual screening for identification of novel 11beta-HSD1 inhibitors. Eur J Med Chem. 2009;44:1167-71 pubmed publisher

Newton P, Davidson P, Macdonald P, Ollerton R, Krum H. Nebulized furosemide for the management of dyspnea: does the evidence support its use?. J Pain Symptom Manage. 2008;36:424-41 pubmed publisher

Pedersen J, Matsson P, Bergström C, Norinder U, Hoogstraate J, Artursson P. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). J Med Chem. 2008;51:3275-87 pubmed publisher

Lisk G, Pain M, Gluzman I, Kambhampati S, Furuya T, Su X, et al. Changes in the plasmodial surface anion channel reduce leupeptin uptake and can confer drug resistance in Plasmodium falciparum-infected erythrocytes. Antimicrob Agents Chemother. 2008;52:2346-54 pubmed publisher

Obach R, Lombardo F, Waters N. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos. 2008;36:1385-405 pubmed publisher

Wassvik C, Holmén A, Draheim R, Artursson P, Bergström C. Molecular characteristics for solid-state limited solubility. J Med Chem. 2008;51:3035-9 pubmed publisher

Temperini C, Cecchi A, Scozzafava A, Supuran C. Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct. Bioorg Med Chem Lett. 2008;18:2567-73 pubmed publisher

Moghal N, Shenoy M. Furosemide and acute kidney injury in neonates. Arch Dis Child Fetal Neonatal Ed. 2008;93:F313-6 pubmed publisher

Baert B, Deconinck E, Van Gele M, Slodicka M, Stoppie P, Bodé S, et al. Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds. Bioorg Med Chem. 2007;15:6943-55 pubmed

Kallet R. The role of inhaled opioids and furosemide for the treatment of dyspnea. Respir Care. 2007;52:900-10 pubmed

Fujikawa M, Nakao K, Shimizu R, Akamatsu M. QSAR study on permeability of hydrophobic compounds with artificial membranes. Bioorg Med Chem. 2007;15:3756-67 pubmed

Diamandis P, Wildenhain J, Clarke I, Sacher A, Graham J, Bellows D, et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 2007;3:268-73 pubmed

May B, Zorn J, Witkop J, Sherrill J, Wallace A, Legname G, et al. Structure-activity relationship study of prion inhibition by 2-aminopyridine-3,5-dicarbonitrile-based compounds: parallel synthesis, bioactivity, and in vitro pharmacokinetics. J Med Chem. 2007;50:65-73 pubmed

Gulbis B, Spencer A. Efficacy and safety of a furosemide continuous infusion following cardiac surgery. Ann Pharmacother. 2006;40:1797-803 pubmed

Schönfelder E, Knüppel T, Tasic V, Miljkovic P, Konrad M, Wühl E, et al. Mutations in Uroplakin IIIA are a rare cause of renal hypodysplasia in humans. Am J Kidney Dis. 2006;47:1004-12 pubmed

Joseph McCarthy D, Parris K, Huang A, Failli A, Quagliato D, Dushin E, et al. Use of structure-based drug design approaches to obtain novel anthranilic acid acyl carrier protein synthase inhibitors. J Med Chem. 2005;48:7960-9 pubmed

Albqami N, Janetschek G. Laparoscopic partial nephrectomy. Curr Opin Urol. 2005;15:306-11 pubmed

Ward K, Nagilla R, Jolivette L. Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human. Xenobiotica. 2005;35:191-210 pubmed

Reyes L, Mañalich R. Long-term consequences of low birth weight. Kidney Int Suppl. 2005;:S107-11 pubmed

Jolivette L, Ward K. Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure. J Pharm Sci. 2005;94:1467-83 pubmed

Caron G, Ermondi G. Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk). J Med Chem. 2005;48:3269-79 pubmed

Aureli L, Cruciani G, Cesta M, Anacardio R, De Simone L, Moriconi A. Predicting human serum albumin affinity of interleukin-8 (CXCL8) inhibitors by 3D-QSPR approach. J Med Chem. 2005;48:2469-79 pubmed

Kiang T, Ensom M, Chang T. UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther. 2005;106:97-132 pubmed

Refsgaard H, Jensen B, Brockhoff P, Padkjaer S, Guldbrandt M, Christensen M. In silico prediction of membrane permeability from calculated molecular parameters. J Med Chem. 2005;48:805-11 pubmed

Humke U, Siemer S, Uder M, Ziegler M. [Long-term outcome of conservative surgery for kidney cancer: survival, blood pressure, and renal function]. Ann Urol (Paris). 2002;36:349-53 pubmed

Moog R, Becmeur F, Dutson E, Chevalier Kauffmann I, Sauvage P, Brunot B. Functional evaluation by quantitative dimercaptosuccinic Acid scintigraphy after kidney trauma in children. J Urol. 2003;169:641-4 pubmed

Delakas D, Karyotis I, Daskalopoulos G, Terhorst B, Lymberopoulos S, Cranidis A. Nephron-sparing surgery for localized renal cell carcinoma with a normal contralateral kidney: a European three-center experience. Urology. 2002;60:998-1002 pubmed

Wilson F, Disse Nicodeme S, Choate K, Ishikawa K, Nelson Williams C, Desitter I, et al. Human hypertension caused by mutations in WNK kinases. Science. 2001;293:1107-12 pubmed

Gutschmidt K, Stenkamp K, Buchheim K, Heinemann U, Meierkord H. Anticonvulsant actions of furosemide in vitro. Neuroscience. 1999;91:1471-81 pubmed

Thompson S, Arden S, Marshall G, Wingrove P, Whiting P, Wafford K. Residues in transmembrane domains I and II determine gamma-aminobutyric acid type AA receptor subtype-selective antagonism by furosemide. Mol Pharmacol. 1999;55:993-9 pubmed

Zangen A, Botzer D, Zangen R, Shainberg A. Furosemide and digoxin inhibit thiamine uptake in cardiac cells. Eur J Pharmacol. 1998;361:151-5 pubmed